AG
CODX

Algert Global’s Co-Diagnostics CODX Stock Holding History

Algert Global’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-669
Closed -$113K – 1195
2022
Q2 		$113K Buy
669
+231
+53% +$35.1K 0.01% 1103
2022
Q1 		$81K Buy
438
+46
+12% +$9.53K 0.01% 1116
2021
Q4 		$105K Buy
+392
New +$103K 0.01% 914

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Algert Global's CODX Position: Q3 2022 in Review

Algert Global sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 669 shares — an estimated $113K sold.

Algert Global first reported a position in CODX in Q4 2021 and held it in 3 quarters. The position peaked at $113K in Q2 2022. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • Algert Global reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Algert Global sold 669 Co-Diagnostics shares in Q3 2022, an estimated $113K.
  • Algert Global first reported a position in Co-Diagnostics in Q4 2021 and held it in 3 quarters.
  • Algert Global's Co-Diagnostics position peaked at $113K in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Algert Global's 13F filing for Q3 2022, filed 15 Nov 2022.